Maternal Obesity Programming of Perivascular Adipose Tissue and Associated Immune Cells: An Understudied Area With Few Answers and Many Questions.
adipose inflammation
leukocyte
maternal obesity
maternal programming
perivascular adipose
Journal
Frontiers in physiology
ISSN: 1664-042X
Titre abrégé: Front Physiol
Pays: Switzerland
ID NLM: 101549006
Informations de publication
Date de publication:
2021
2021
Historique:
received:
21
10
2021
accepted:
09
12
2021
entrez:
7
2
2022
pubmed:
8
2
2022
medline:
8
2
2022
Statut:
epublish
Résumé
At present, the worldwide prevalence of obesity has become alarmingly high with estimates foreshadowing a continued escalation in the future. Furthermore, there is growing evidence attributing an individual's predisposition for developing obesity to maternal health during gestation. Currently, 60% of pregnancies in the US are to either overweight or obese mothers which in turn contributes to the persistent rise in obesity rates. While obesity itself is problematic, it conveys an increased risk for several diseases such as diabetes, inflammatory disorders, cancer and cardiovascular disease (CVD). Additionally, as we are learning more about the mechanisms underlying CVD, much attention has been brought to the role of perivascular adipose tissue (PVAT) in maintaining cardiovascular health. PVAT regulates vascular tone and for a significant number of individuals, obesity elicits PVAT disruption and dysregulation of vascular function. Obesity elicits changes in adipocyte and leukocyte populations within PVAT leading to an inflammatory state which promotes vasoconstriction thereby aiding the onset/progression of CVD. Our current understanding of obesity, PVAT and CVD has only been examined at the individual level without consideration for a maternal programming effect. It is unknown if maternal obesity affects the propensity for PVAT remodeling in the offspring, thereby enhancing the obesity/CVD link, and what role PVAT leukocytes play in this process. This perspective will focus on the maternal contribution of the interplay between obesity, PVAT disruption and CVD and will highlight the leukocyte/PVAT interaction as a novel target to stem the tide of the current obesity epidemic and its secondary health consequences.
Identifiants
pubmed: 35126181
doi: 10.3389/fphys.2021.798987
pmc: PMC8815821
doi:
Types de publication
Journal Article
Langues
eng
Pagination
798987Informations de copyright
Copyright © 2022 Corken and Thakali.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
CMAJ. 1997 Jul 1;157 Suppl 1:S26-31
pubmed: 9220951
Circ Res. 2014 May 9;114(10):1640-60
pubmed: 24812352
JAMA. 2012 Feb 1;307(5):491-7
pubmed: 22253363
Placenta. 2009 Sep;30(9):752-60
pubmed: 19632719
J Immunol. 2010 Dec 1;185(11):6947-59
pubmed: 21037091
Br J Pharmacol. 2017 Oct;174(20):3496-3513
pubmed: 28063251
Cureus. 2020 Nov 13;12(11):e11473
pubmed: 33329969
PLoS One. 2013 Oct 17;8(10):e76961
pubmed: 24146946
Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2594-9
pubmed: 16195477
JAMA. 2009 Jul 22;302(4):401-11
pubmed: 19622819
Nat Med. 2009 Aug;15(8):930-9
pubmed: 19633656
Acta Physiol (Oxf). 2018 Dec;224(4):e13126
pubmed: 29896909
Prev Med. 1987 Mar;16(2):235-51
pubmed: 3588564
Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):558-69
pubmed: 25593133
Cardiovasc Res. 2013 Aug 1;99(3):422-31
pubmed: 23674516
Drug Discov Today Dis Mech. 2013 Jun 1;10(1-2):
pubmed: 24003334
Circulation. 2008 Jun 24;117(25):3171-80
pubmed: 18559702
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1094-1109
pubmed: 32188271
JAMA. 1978 Oct 6;240(15):1607-10
pubmed: 691146
Am J Physiol Regul Integr Comp Physiol. 2018 Dec 1;315(6):R1085-R1095
pubmed: 30256681
Future Sci OA. 2016 Aug 19;2(3):FSO137
pubmed: 28031980
Int J Obes (Lond). 2016 Aug;40(8):1205-14
pubmed: 27102050
Arch Gynecol Obstet. 2014 Feb;289(2):247-57
pubmed: 24141389
Obstet Gynecol. 2011 Jul;118(1):63-70
pubmed: 21691164
Exp Physiol. 2020 Sep;105(9):1440-1443
pubmed: 32648363
J Lipid Res. 2008 Sep;49(9):1894-903
pubmed: 18503031
Glob Pediatr Health. 2019 Dec 1;6:2333794X19891305
pubmed: 31832491
J Hypertens. 1994 Dec;12(12):1433-7
pubmed: 7706705
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1621-30
pubmed: 24833795
Front Physiol. 2016 Jul 12;7:295
pubmed: 27462277
Cardiovasc Diabetol. 2018 Oct 10;17(1):134
pubmed: 30305178
Obesity (Silver Spring). 2013 Jul;21(7):1467-73
pubmed: 23585283
BMC Med. 2019 Nov 25;17(1):212
pubmed: 31760948
Diabetes. 2013 Nov;62(11):3727-35
pubmed: 23884886
Diabetes. 2005 Aug;54(8):2277-86
pubmed: 16046292
Front Physiol. 2018 Feb 09;9:51
pubmed: 29479319
Nat Med. 2009 Aug;15(8):914-20
pubmed: 19633658
Am J Hypertens. 2009 Jan;22(1):59-67
pubmed: 19039307
Am J Physiol Endocrinol Metab. 2013 Nov 15;305(10):E1195-207
pubmed: 24045869
Hypertension. 2017 May;69(5):770-777
pubmed: 28320849
Nat Rev Dis Primers. 2017 Jun 15;3:17034
pubmed: 28617414
Circulation. 2012 Aug 28;126(9):1067-78
pubmed: 22855570
Nat Rev Endocrinol. 2019 Aug;15(8):456-478
pubmed: 31270440
Am J Clin Nutr. 1998 Mar;67(3 Suppl):563S-72S
pubmed: 9497171
PLoS One. 2014 Aug 22;9(8):e105262
pubmed: 25148116
BMJ. 2013 Aug 13;347:f4539
pubmed: 23943697
Acta Obstet Gynecol Scand. 2014 Nov;93(11):1085-9
pubmed: 25231923
Sci Rep. 2019 Nov 5;9(1):16027
pubmed: 31690792
Case Manager. 2004 Nov-Dec;15(6):47-9; quiz 50
pubmed: 15557992
Pediatr Allergy Immunol. 2015 Jun;26(4):344-51
pubmed: 25858482
Pediatrics. 2006 Dec;118(6):e1644-9
pubmed: 17142494
Obesity (Silver Spring). 2016 Mar;24(3):597-605
pubmed: 26916240
Cardiovasc Drugs Ther. 2018 Oct;32(5):481-502
pubmed: 30171461
Biomed Res Int. 2014;2014:418975
pubmed: 24967364
Hypertension. 2003 Nov;42(5):878-84
pubmed: 12975389
J Cardiol Cardiovasc Sci. 2019;3(4):10-15
pubmed: 32411947
Nat Rev Endocrinol. 2014 Aug;10(8):455-465
pubmed: 24935119
Int J Obes (Lond). 2019 Sep;43(9):1701-1711
pubmed: 30705391
Nat Med. 2013 Oct;19(10):1252-63
pubmed: 24100998
Nat Rev Immunol. 2011 Oct 14;11(11):723-37
pubmed: 21997792
Curr Pharm Des. 2014;20(4):603-8
pubmed: 23688011
Lancet Diabetes Endocrinol. 2017 Jan;5(1):53-64
pubmed: 27743978
J Clin Endocrinol Metab. 2009 Nov;94(11):4275-83
pubmed: 19820018
Diabetes. 2015 Jan;64(1):90-103
pubmed: 25048196
Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H193-201
pubmed: 20435848
Nutrients. 2019 Feb 27;11(3):
pubmed: 30818740
Neuroscience. 2020 Nov 1;447:122-135
pubmed: 32032668
J Sch Health. 2010 Apr;80(4):186-92
pubmed: 20433644
Pediatrics. 2016 Mar;137(3):e20151662
pubmed: 26908707
Paediatr Child Health. 2009 Mar;14(3):177-82
pubmed: 20190900
Cardiovasc Res. 2013 Mar 15;97(4):696-704
pubmed: 23263331
Circulation. 2008 Jun 24;117(25):3238-49
pubmed: 18574061
Am J Physiol Endocrinol Metab. 2010 Dec;299(6):E968-75
pubmed: 20876759
EBioMedicine. 2018 Apr;30:14-28
pubmed: 29526577
PLoS One. 2014 Dec 11;9(12):e114895
pubmed: 25501574
Elife. 2020 Jun 19;9:
pubmed: 32553115
Am J Physiol Regul Integr Comp Physiol. 2010 Sep;299(3):R711-22
pubmed: 20631295
Front Physiol. 2020 Feb 11;11:58
pubmed: 32116768
Nat Immunol. 2015 Apr;16(4):376-85
pubmed: 25729921
BMJ. 2021 Apr 13;373:n956
pubmed: 33849923
Curr Diab Rep. 2013 Feb;13(1):27-33
pubmed: 23188593
Trends Endocrinol Metab. 2018 Oct;29(10):675-685
pubmed: 30104112
Acta Paediatr. 2019 Jan;108(1):37-43
pubmed: 30144170
Obes Facts. 2017;10(5):483-492
pubmed: 29020674
Curr Oncol Rep. 2011 Feb;13(1):71-6
pubmed: 21080117
Clin Obstet Gynecol. 2014 Sep;57(3):508-15
pubmed: 24936914
Hypertension. 2013 Feb;61(2):290-5
pubmed: 23248147
J Clin Invest. 2007 Jun;117(6):1718-26
pubmed: 17549259
Circ Res. 2004 Mar 5;94(4):534-41
pubmed: 14699015
Br J Pharmacol. 2017 Oct;174(20):3514-3526
pubmed: 28236429
PLoS Comput Biol. 2009 Mar;5(3):e1000324
pubmed: 19325873
Endocrinology. 2012 Dec;153(12):5961-71
pubmed: 23070543
BMC Public Health. 2017 Aug 29;17(1):683
pubmed: 28851330
Front Physiol. 2015 May 13;6:158
pubmed: 26029119
J Nutr Biochem. 2012 Mar;23(3):265-71
pubmed: 21543208
Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):78-85
pubmed: 26586660
Nature. 2013 Apr 25;496(7446):445-55
pubmed: 23619691
J Diabetes Res. 2018 Nov 4;2018:3407306
pubmed: 30525052
J Physiol Pharmacol. 2019 Apr;70(2):
pubmed: 31443092
Diabetes Metab Res Rev. 2018 Oct;34(7):e3042
pubmed: 29931823
Front Pharmacol. 2021 Jun 22;12:697720
pubmed: 34239444
JAMA Intern Med. 2016 Feb;176(2):210-6
pubmed: 26784837
Int J Obes Suppl. 2020 Jul;10(1):27-34
pubmed: 32714510
Circ Res. 2020 May 22;126(11):1549-1564
pubmed: 32437299
Appetite. 2016 Jul 1;102:70-6
pubmed: 26898319
Diabetes. 2007 Aug;56(8):1960-8
pubmed: 17620421
J Clin Invest. 2003 Dec;112(12):1796-808
pubmed: 14679176
Semin Reprod Med. 2011 May;29(3):237-45
pubmed: 21710399
Cell Mol Life Sci. 2019 Feb;76(4):777-789
pubmed: 30448891
Pediatr Res. 2016 Jan;79(1-1):3-12
pubmed: 26375474
Pharmacoeconomics. 2015 Jul;33(7):673-89
pubmed: 25471927
J Hypertens. 2012 Jun;30(6):1047-55
pubmed: 22573071
J Nutr Metab. 2013;2013:517384
pubmed: 23762542
Front Physiol. 2021 Mar 17;12:616055
pubmed: 33815135